Viscosupplementation Global Analysis & Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023

  • ID: 3734994
  • Report
  • Region: Global
  • 140 Pages
  • Occams Business Research and Consulting
1 of 4
Viscosupplementation Market is Estimated to Be Around $1756 Million And is Poised to Grow at 6% CAGR During 2016-2022

FEATURED COMPANIES

  • Ab Enzymes
  • Amino
  • Cargill Incorporation.
  • DSM
  • Evonik Industries Ag
  • Hoffmann-La Roche
  • MORE
Viscosupplementation is the latest treatment which is being rapidly adapted these days for the treatment of osteoarthritis. It is a method of injecting hyaluronic acid in stiff joints specially knees. Due to the global adoption, the Viscosupplementation market is expected to hit $1756 million during 2015-2021 growing at an impressive CAGR of 6% during the forecast period. The main reason behind a solid growth of Viscosupplementation market on the global level is the rapid rise in the elderly population suffering from osteoarthritis. This elderly population is expected to increase in future due to advancement in the healthcare facilities which would ultimately require Disco supplementation for patients suffering from osteoarthritis during the forecast period.

Further, Intra-articular Viscosupplementation with hyaluronic acid (HA) is gaining a good acceptance as a therapeutic alternative to knee replacement surgery in OA in the past decade. North America is expected to be the largest market for Viscosupplementation during the forecast period in which the US being the major contributor to the global market for Viscosupplementation. On the flip side, APAC is seeing good growth in demand for Viscosupplementation fluids due to rising cases of osteoarthritis in countries such as India and China. However, the growing concern of physicians who updated American Academy of Orthopedic Surgeons (AAOS) and Osteoarthritis Research Society International (OARSI) treatment guidelines for knee OA will affect in rising insurance denials for Viscosupplementation. Further the price competition and product differentiation are some of the factors that can restrict the smooth growth of the market during the forecast period.

Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ab Enzymes
  • Amino
  • Cargill Incorporation.
  • DSM
  • Evonik Industries Ag
  • Hoffmann-La Roche
  • MORE
1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Market Definition And Scope
2.2. Key Findings
2.3. Parametric Analysis
2.4. Key Market Insights
2.4.1. Top 3 Emerging Countries
2.4.2. Top 3 Revenue Generating Segments
2.4.3. Top Growing Mark
2.4.4. Top 3 Geography
2.5. Competitive Landscape
2.5.1. Market Share Analysis
2.5.2. Top Winning Strategies
2.5.3. Case Studies: Top Competitive Moves
2.6. Porter’S Five Force Model
2.6.1. Threat Of New Entrants
2.6.2. Threat Of Substitute Products Or Services
2.6.3. Bargaining Power Of Buyer
2.6.4. Bargaining Power Of Supplier
2.6.5. Intensity Of Competitive Rivalry
2.7. Key Buying Criteria
2.8. Strategic Recommendations
2.9. Strategic Conclusions

3. Market Determinants
3.1. Market Drivers
3.1.1. Rising Prevalence Of Oa
3.1.2. Viscosupplementation Delays Total Knee Replacement
3.1.3. Side Effects Of Nsaids, Corticosteroids, And Narcotics
3.1.4. Direct-To-Consumer Marketing
3.2. Market Restraints
3.2.1. Unfavourable Reimbursement Scenario
3.2.2. Pricing Erosion
3.2.3. Cost Effective Pharmacological Therapies
3.2.4. Rising Popularity Of Prp Injection To Impact Viscosupplementation
3.2.5. Cost-Conscious Patients In Emerging Countries
3.3. Market Opportunities
3.3.1. Expanding Indications
3.3.2. New Generation Ha Derivatives
3.3.3. Increased Use After Arthroscopic Surgeries
3.3.4. Self-Pay Market
3.3.5. Emerging Countries

4. Sector Analysis
4.1. Parent Market
4.2. Competitors Market
4.3. Alternative Market

5. Market Segmentation

6. Geographic Analysis
6.2. North America
6.2.1. North America Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.2.2. North America Viscosupplementation Market By Region, 2014-2021 ($Billion)
6.2.2.1. Us Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.2.2.2. Canada Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.2.2. 3. Mexico Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.3 Europe
6.3.1. Europe Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.3.2. Europe Viscosupplementation Market By Region, 2014-2021 ($Billion)
6.3.2.1. Germany Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.3.3.2. Uk Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.3.3.3. Russia Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.4. Asia Pacific
6.4.1. Asia Pacific Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.4.2. Asia Pacific Viscosupplementation Market By Region, 2014-2021 ($Billion)
6.4.2.1. China Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.4.2.2. India Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.4.2.3. South Korea Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.5. Middle East & Africa
6.5.1. Middle East & Africa Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.5.2. Middle East & Africa Viscosupplementation Market By Region, 2014-2021 ($Billion)
6.6. Central & South America
6.6.1. Central & South America Viscosupplementation Market By Application, 2014-2021 ($Billion)
6.6.2. Central & South America Viscosupplementation Market By Region, 2014-2021 ($Billion)
6.6.2.1. Brazil Viscosupplementation Market By Application, 2014-2021 ($Billion)

7 Company Profiles
7.1. Ajinomoto Company Incorporation
7.2. Ab Enzymes
7.3. Basf Se
7.4. Amano Enzyme Inc
7.5. The Dow Chemical Company
7.6. Archer Daniels Midland Company
7.7. Novozymes A/S
7.8. Cargill Incorporation.
7.9. Evonik Industries Ag
7.10. Du Pont Danisco A/S
7.11. Dsm
7.12. Chr
7.13. Fuso Chemical
7.14. Hoffmann-La Roche
7.15. Amino

Table List
Table 1 Us Procedureal Trends For Viscosupplementation, By Joint Type, 2014-2021
Table 2 Us Procedureal Trends For Viscosupplementation, By Treatment Regimen, 2014-2021
Table 3 5Eu Procedureal Trends For Viscosupplementation, By Joint Type, 2014-2021
Table 4 Europe Procedure Trends For Viscosupplementation, By Treatment Regimen, 2014-2021
Table 5 Apac Procedure Trends For Viscosupplementation, By Joint Type, 2014-2021
Table 6 Apac Procedure Trends For Viscosupplementation, By Treatment Regimen, 2014-2021
Table 7 Brazil Procedure Trends For Viscosupplementation, By Joint Type, 2014-2021
Table 8 Brazil Procedure Trends For Viscosupplementation, By Treatment Regimen, 2014-2021
Table 9 Differences Between Us Fda Approval And Eu Ce Marking Of Medical Devices
Table 10 Us Medicare Asps* For Viscosupplementation Products (2014-2015)
Table 11 Problems Associated With Knee Replacement
Table 12 Side-Effects Caused By Nsaids
Table 13 Side Effects Of Corticosteroids
Table 14 Side Effects Of Narcotics
Table 15 Viscosupplementation Dosing
Table 16 Medical Necessities For The Process
Table 17 Total Health Expenditure Per Capita Income In $ In 2015
Table 18 Product Profile (Adant)
Table 19 Product Profile (Arthrum)
Table 20 Arthrum Composition And Ratio In Capsules
Table 21 Product Profile (Curavisc)
Table 22 Product Profile (Durolane)
Table 23 Product Profile (Euflexxa)
Table 24 Product Profile (Fermathron)
Table 25 Product Profile (Gel-One)
Table 26 Product Profile (Go-On)
Table 27 Product Profile (Jonexa)
Table 28 Product Profile (Jonexa)
Table 29 Product Profile (Neovisc)
Table 30 Product Profile (Orthovisc And Monovisc)
Table 31 Product Profile (Ostenil)
Table 32 Product Profile (Recosyn)
Table 33 Product Profile (Renehavis)
Table 34 Product Profile (Supartz/Artz)
Table 35 Product Profile (Suplasyn)
Table 36 Product Profile (Suvenyl)
Table 37 Product Profile (Synocrom)
Table 38 Product Profile (Synolis V-A)
Table 39 Product Profile (Synovial)
Table 40 Product Profile (Synvisc And Synvisc-One)
Table 41 Each 1 Ml Of Gel-Syn Contains:
Table 42 Seikagaku Corporation Products Portfolio
Table 43 Scot Analysis - Seikagaku Corporation
Table 44 Bioventus Llc Products Portfolio
Table 45 Scot Analysis - Bioventus Llc
Table 46 Depuy Synthes Products Portfolio
Table 47 Scot Analysis - Depuy Synthes
Table 48 Zimmer Biomet Inc Products Portfolio
Table 49 Scot Analysis - Zimmer Biomet Inc
Table 50 Sanofi Products Portfolio
Table 51 Scot Analysis - Sanofi
Table 52 Anika Therapeutics Products Portfolio
Table 53 Scot Analysis - Anika Therapeutics
Table 54 Chugai Pharmaceuticals Products Portfolio
Table 55 Scot Analysis - Chugai Pharmaceuticals
Table 56 Ferring Holdings Products Portfolio
Table 57 Scot Analysis - Ferring Holdings
Table 58 Fidia Farmaceutici S.P.A. Products Portfolio
Table 59 Scot Analysis - Fidia Farmaceutici S.P.A.
Table 60 Meda Ab Products Portfolio
Table 61 Scot Analysis - Meda Ab
Table 62 Global Viscosupplementation Market By Region, 2014-2021 ($ Million)
Table 63 Global Viscosupplementation Market Revenue ($ Million), By Segment, 2014-2021
Table 64 Single Injection In Viscosupplementation Cost And Different Brand
Table 65 One-Injection Market, By Region 2014-2021($Million)
Table 66 Three-Injection Market, By Region 2014-2021($ Million)
Table 67 Multiple Injections In Viscosupplementation
Table 68 Global Viscosupplementation Market By Geography, 2014-2021 ($ Million)
Table 69 Us Visco Supplementation Market By Revenue ($ Million) 2014-2021
Table 70 France Visco Supplementation Market By Revenue ($ Million) 2014-2021
Table 71 Germany Visco Supplementation Market By Revenue ($ Million), 2014-2021
Table 72 Spain Viscosupplementation Market By Revenue ($ Million), 2014-2021
Table 73 Uk Visco Supplementation Market By Revenue($ Million), 2014-2021
Table 74 Japan Viscosupplementation Market By Revenue ($ Million), 2014-2021
Table 75 Brazil Viscosupplementation Market By Revenue($ Million), 2014-2021
Table 76 China Visco Supplementation Market By Revenue($ Million), 2014-2021
Table 77 India Viscosupplementation Market By Revenue ($ Million), 2014-2021

Figures List

Figure 1 Global Viscosupplemetation Procedural Trends By Treatment Regime (%) 2014 And 2021
Figure 2 Global Viscosupplementation Procedural Trends By Joint Type (%) 2014 And 2021
Figure 3 Us Adoption Trend For Viscosupplementation, By Treatment Regimen, 2014
Figure 4 Us Procedure Trends For Viscosupplementation, By Treatment Regimen, 2012-2021
Figure 5 5Eu Procedure Trends For Viscosupplementation, By Joint Type, 2014
Figure 6 5Eu Adoption Trends For Viscosupplementation, By Treatment Regimen, 2014
Figure 7 5Eu Procedure Trends For Viscosupplementation, By Treatment Regimen, 2012-2021
Figure 8 Apac Procedure Trends For Viscosupplementation, By Treatment Regimen, 2012-2021
Figure 9 Apac Procedure Trends For Viscosupplementation, By Joint Type, 2014
Figure 10 Apac Adoption Trend For Viscosupplementation, By Treatment Regimen, 2014
Figure 11 Brazil Procedure Trends For Viscosupplementation, By Joint Type, 2014
Figure 12 Brazil Adoption Trend For Viscosupplementation, By Treatment Regimen, 2014
Figure 13 Brazil Procedure Trends For Viscosupplementation, By Treatment Regimen, 2012-2021
Figure 14 Global Viscosupplementation Market Access By Region 2014-2021 (%)
Figure 15 Payer Mix For Viscosupplementation In The Us, 2014
Figure 16 Payer Mix For Viscosupplementation In France, 2014
Figure 17 Payer Mix For Viscosupplementation In The Uk, 2014
Figure 18 Payer Mix For Viscosupplementation In Spain, 2014
Figure 19 Payer Mix For Viscosupplementation In China, 2014
Figure 20 Life Time Risk Of Symptomatic Osteoarthritis
Figure 21 Global Prevalence Arthritis By Age (%) In 2014
Figure 22 Commonly Used Nsaids, Corticosteroids, Narcotics
Figure 23 Advantages Of Direct-To-Consumer Marketing
Figure 24 The Common Pharmacological Therapies Available For Oa
Figure 25 Average Per Capita Income In Developed And Developing Countries In 2014
Figure 26 Hyaluronic Acid Derivatives
Figure 27 Steps Included In Self Pay Market
Figure 28 Growth Of Viscosupplementation Market In Apac Region In Us $ Million 2015-2020
Figure 29 Features Of Neovisc
Figure 30 Us Viscosupplementation Market By Joint Type In 2014(%)
Figure 31 France, Germany, Italy Spain And Uk Viscosupplementation Market Growth 2014-2021($ Million)
Figure 32 India, China And Japan Viscosupplementation Market Growth 2014-2021($ Million)
Figure 33 Global Viscosupplementation One-Injection Market Revenue ($M) 2012-2021
Figure 34 Global Viscosupplementation Three-Injection Market Revenue ($M), By Region, 2012-2021
Figure 35 Five-Injection Market, By Country 2012-2021($ Million)
Figure 36 Global Viscosupplementation Five-Injection Market Revenue ($ Million), By Region, 2012-2021
Figure 37 Growth In Number Of Patients Suffering From Osteoarthritis By Gender (2005-2030)
Figure 38 France Viscosupplementation Market Revenue $ Million 2014-2021
Figure 39 Causes Of Osteoarthritis
Figure 40 Germany Viscosupplementation Market Revenue $Million 2014-2021
Figure 41 Hip Replacement Surgery Per 100 000 Population 2013
Figure 42 Italy Viscosupplementation Market Revenue $ Million 2014-2021
Figure 43 Reduction In Pain And Stiffness After Mono Injection
Figure 44 Spain Viscosupplementation Market Revenue $ Million 2014-2021
Figure 45 Number Of Osteoarthritis Patients In Spain By Age
Figure 46 Knee Operations For Obese People In 2012-13 By Gender
Figure 47 Uk Viscosupplementation Market Revenue $ Million 2014-2021
Figure 48 Japan Viscosupplementation Market Revenue $ Million 2014-2021
Figure 49 Prevalence Of Knee Osteoarthritis In Japan By Gender In 2014
Figure 50 Brazil Viscosupplementation Market Revenue $ Million 2014-2021
Figure 51 Health Expenditure As Percentage Of Gdp In 2013
Figure 52 India Viscosupplementation Market Revenue $ Million 2014-2021
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Ab Enzymes
- Ajinomoto Company Incorporation
- Amano Enzyme Inc
- Amino
- Archer Daniels Midland Company
- Basf Se
- Cargill Incorporation.
- CHR
- DSM
- Du Pont Danisco A/S
- Evonik Industries Ag
- Fuso Chemical
- Hoffmann-La Roche
- Novozymes A/S
- The DOW Chemical Company
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll